PRESS RELEASE published on 03/19/2026 at 08:00, 7 months 2 days ago ecotel publishes 2025 Annual Report: Strategic course confirmed – Revenue up 8%, Free Cash Flow significantly increased ecotel communication ag publishes 2025 Annual Report highlighting 8% revenue increase and significant Free Cash Flow growth. Strategic course confirmed for future growth in German telecommunications market Growth Strategy Revenue Increase Ecotel Communication AG 2025 Annual Report Telecommunications Market
PRESS RELEASE published on 03/19/2026 at 08:00, 7 months 2 days ago Transaction in Own Shares Molten Ventures Plc (GROW) announces the purchase of 20,000 own ordinary shares at prices ranging from 464.60p to 474.60p per share Share Repurchase Molten Ventures Plc GROW Share Transaction Deutsche Bank
PRESS RELEASE published on 03/19/2026 at 08:00, 7 months 2 days ago 2025 Full Year Results Announcement Gulf Keystone Petroleum Ltd announces 2025 Full Year Results, achieving strong operational and financial performance, operating in Kurdistan. CEO highlights operational deliveries, increased production, and growth projects. Suspends 2026 guidance due to regional conflicts Financial Results Operational Performance Gulf Keystone Petroleum Ltd Kurdistan 2025 Full Year Results
PRESS RELEASE published on 03/19/2026 at 08:00, 7 months 2 days ago Interim dividend information Gulf Keystone Petroleum Ltd. announces $12.5 million interim dividend of $0.0575 per Common Share in connection with 2025 Full Year Results. Payment date set for 27 April 2026 Dividend Payment Interim Dividend Payment Date Gulf Keystone Petroleum Ltd. 2025 Full Year Results
PRESS RELEASE published on 03/19/2026 at 08:00, 7 months 2 days ago OHB SE: Consolidated financial statements 2025 OHB SE reports significant growth in 2025 with total revenues up by 21%, order intake at EUR 2,078 million, and dividend recommendation of EUR 0.60. Key milestones achieved in space systems segment Financial Statements Order Intake OHB SE Profitable Growth Space Industry
PRESS RELEASE published on 03/19/2026 at 07:50, 7 months 2 days ago AFYREN obtains ISO 9001 certification, a globally acknowledged standard of rigor and performance, for its AFYREN NEOXY plant AFYREN obtains ISO 9001 certification for AFYREN NEOXY plant, showcasing commitment to operational excellence and sustainable solutions Operational Excellence Sustainable Solutions ISO 9001 Certification AFYREN Biobased Ingredients
PRESS RELEASE published on 03/19/2026 at 07:35, 7 months 2 days ago Lenzing advances its transformation: Higher EBITDA, stronger free cash flow and more than EUR 200 million in cost savings Lenzing Group reports higher EBITDA, stronger free cash flow, and over EUR 200 million in cost savings for 2025 despite challenging market conditions Financial Results EBITDA Free Cash Flow Cost Savings Lenzing Group
PRESS RELEASE published on 03/19/2026 at 07:30, 7 months 2 days ago Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS AL-S Pharma AG presents additional Phase 2 data of lead program AP-101 at AD/PD International Conference showing disease modification in ALS patients. AP-101 targets misfolded SOD1 to inhibit disease progression ALS Phase 2 Data AP-101 AL-S Pharma AG SOD1
PRESS RELEASE published on 03/19/2026 at 07:30, 7 months 2 days ago The Nordex Group receives orders totaling 54 MW from Prowind in Germany Nordex Group secures orders totaling 54 MW from Prowind in Germany, highlighting strong collaboration and focus on state-of-the-art technology and sustainable profitability Renewable Energy Germany Nordex Group Wind Turbines Prowind
PRESS RELEASE published on 03/19/2026 at 07:30, 7 months 2 days ago Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation Evotec receives $10 M milestone from Bristol Myers Squibb for Phase 1 clinical study initiation of BMS-986506 in clear cell renal cell carcinoma. Collaboration focuses on protein degradation for cancer treatment Oncology Clinical Study Evotec Bristol Myers Squibb Protein Degradation
Published on 10/21/2026 at 15:00, 1 hour 13 minutes ago Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Published on 10/21/2026 at 14:40, 1 hour 33 minutes ago Axo Metals Receives Approval to Trade on the OTCQB Venture Market Under the Symbol AXOCF
Published on 10/21/2026 at 14:30, 1 hour 43 minutes ago Fermi Provides Letter to Shareholders from CEO Lee McIntire on Financing Fermi's Next Chapter
Published on 10/21/2026 at 14:00, 2 hours 13 minutes ago Nine Mile Metals DDH WD-26-18 Intersects A High Grade VMS Lens, Returning 7.13% Cu-Eq Over 11.65 M Including 9.93% Cu-Eq Over 6.70 M And 10.46% Cu-Eq Over 4.80 M, With An Additional Upper 31.50m Copper Stringer Zone
Published on 10/21/2026 at 13:45, 2 hours 28 minutes ago Quartz to Commence Phase 5 Drilling at Maestro, Targeting Prodigy Expansion and Multiple Potential Sulphide-Mineralized Systems
Published on 10/21/2026 at 15:15, 58 minutes ago Circus Q3 2026: AI Robotics Fleet Scales Across Europe as Ecosystem and Operations Reach Maturity
Published on 10/21/2026 at 15:12, 1 hour 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/21/2026 at 15:11, 1 hour 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Greenland Energy Company
Published on 10/21/2026 at 15:10, 1 hour 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/21/2026 at 15:10, 1 hour 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/21/2026 at 07:00, 9 hours 13 minutes ago Edenred reports sound growth in the first nine months of 2026 and confirms its guidance for the full year
Published on 10/20/2026 at 19:47, 20 hours 26 minutes ago Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)